MetaCap

Heartflow (HTFL) vs Envista (NVST)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Heartflow (HTFL) has outperformed Envista (NVST) over the past year, gaining 51.3% versus a gain of 15.2%. Heartflow is the larger company by market cap ($4.10 billion vs $3.67 billion), about 1.1 times the size. On valuation, Envista trades at a lower trailing P/E (6.0x vs 69.7x for Heartflow).

Envista converts more of its revenue into profit, with a net margin of 1.7% versus -66.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

HTFL+51.35%NVST+15.18%
+103%+31%-40%
Nov 21, 20251 yearNov 20, 2026
HTFL+49.79%NVST+11.00%
+96%+28%-40%
Aug 11, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

HTFL versus NVST key metrics
MetricHTFLNVST
Share price$46.69$22.91
Market cap$4.10B$3.67B
1-day change+4.62%-1.55%
YTD return+60.17%+5.53%
1-year return+51.35%+15.18%
5-year return—-42.84%
P/E ratio (TTM)69.695.95
Forward P/E—13.68
EPS (TTM)$0.67$3.85
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$176.03M$2.72B
Revenue growth (YoY)+39.92%+8.32%
Net income (latest FY)$-116.79M$47.00M
Gross margin76.80%54.67%
Operating margin-36.39%7.95%
Net margin-66.35%1.73%
52-week high$60.66$30.42
52-week low$20.13$19.67
Distance from 52-week high-23.02%-24.69%
Analyst consensusstrong_buybuy
Avg. price target upside+39.22%+26.23%
Average volume1.84M2.87M
Shares outstanding87.89M160.34M
Employees84312,000
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • HTFL has outperformed NVST by 36.2 percentage points over the past year.
  • Heartflow trades at a higher earnings multiple (69.7x vs 6.0x trailing P/E).
  • Envista is more profitable, keeping 1.7 cents of every revenue dollar as net income versus -66.3 cents for Heartflow.
  • Heartflow grew revenue faster in its latest fiscal year (+39.92% vs +8.32%).

About Heartflow

HTFL stock →

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.

Health Care · Medical/Dental Instruments · 843 employees

About Envista

NVST stock →

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.

Health Care · Medical/Dental Instruments · 12,000 employees

HTFL vs NVST FAQ

Which is bigger, Heartflow or Envista?

Heartflow (HTFL) is larger, with a market capitalization of $4.10B compared with $3.67B for Envista (NVST).

Which stock has performed better over the past year, HTFL or NVST?

HTFL returned +51.35% over the past 12 months, compared with +15.18% for NVST (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, HTFL or NVST?

NVST has the lower trailing P/E at 6.0, versus 69.7 for HTFL. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Heartflow and Envista in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons